Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Expanding Possibilities in Animal Health

Products are for professional/laboratory use only.

Multiplex assays simplified the discovery and understanding of complex biological systems and processes in veterinary medicine, animal health, animal models, and human health.

Multiplex Biomarker Detection immunoassays save time, money, and sample volume by increasing the number of data points generated from a single assay.

MILLIPLEX® kits can analyse the following animal species:

Agricultural Animals Laboratory Animals Companion Animals 
– Bovine
– Equine
– Porcine
– Ovine
– Chicken
– Mouse
– Rat
– Non-Human Primate
– Canine
– Feline

 

Look closer:

Ovine Cytokine/Chemokine Panel 1: Cat. No. SCYT1-91K →

Chicken Cytokine/Chemokine Panel 1: Cat. No. GCYT1-16K → 

Bovine Cytokine/Chemokine Panel 1: Cat. No. BCYT1-33K →

Canine Pituitary Expanded Panel: Cat. No. CANPIT-96K →

Non-Human Primate Cytokine/Chemokine/Growth Factor Panel A: Cat. No. PRCYTA-40K →

 

Learn more about Multiplex Asssays for Veterinary Medicine

Download Brochure >



Request a Quote

Request Quote

Recent Posts

Advancing Stroke Research with Luminex® MAGPIX®

Identifying Neuroinflammatory Signals Through Multiplex Analysis We’re proud to showcase groundbreaking research from our valued customers at the Hudson Institute of Medical Research and Monash…

Read full article

Choosing the Right Luminex® xMAP® Immunoassay Platform for Your Research

In today’s fast-paced research environment, selecting the right biomarker detection platform is crucial for generating reliable, reproducible data. Whether you’re running a small academic lab…

Read full article

VacciCheck Veterinarian Educational Seminar

We’re inviting fellow veterinarians to the VacciCheck Education Seminar.  Discover the latest advancements in veterinary titre testing and connect with fellow veterinary professionals at this…

Read full article